Early next year, researchers at the University of North Carolina (UNC) at Chapel Hill will begin enrolling infants in a clinical trial to test the effectiveness of inhaled saline as a treatment for cystic fibrosis lung disease. Inhaled saline solution is salty saltwater—almost twice as salty as the Atlantic Ocean.